Search NLS News

The European Patent Office (EPO) has honoured Hungarian-American researcher Katalin Karikó with the European Inventor Award 2022 in the category “Lifetime achievement”, for her seminal work in developing modified messenger RNA (mRNA) for vaccines and medical therapies. For more than four decades, Karikó has championed the therapeutic potential of mRNA, overcoming both scepticism and countless […]

Bavarian Nordic has announced that the European Medicines Agency (EMA) has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in active immunization for the prevention of lower respiratory tract disease (LRTD) caused by Respiratory Syncytial Virus (RSV) in adults ≥60 years of age. There are no approved vaccines for RSV, and access […]

Dr Martin Oeggerli at Micronaut GmBH, Basel, Switzerland, is this year’s winner of the Lennart Nilsson Award. Martin Oeggerli holds a PhD in medical molecular biology. Since 2005, he works as a freelance science photographer, collaborating with scientists in Basel and elsewhere. Bring out their inherent beauty Martin Oeggerli uses the scanning electron microscope to […]

Straight after ASCO, BIO 2022 was back in person in San Diego, June 13-17. Some 15,000 delegates from around the world attended. The exhibition hall was packed with national and regional pavilions from every country with skin in the life science game (except, surprisingly and controversially, the UK) and the special biomanufacturing area has grown […]

The US Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for the combination of TG01 and QS-21 STIMULON. The IND is a major milestone for the TG mutant RAS program, and represents the first time that a TG vaccine is authorized for clinical trials in the USA, states the company. […]

Immunovia has announced results from the PanFAM-1 study, a prospective, multi-center, investigational study, designed to assess the performance of the IMMray PanCan-d test in early detection of pancreatic ductal adenocarcinoma (PDAC) in high-risk populations. The IMMray PanCan-d test met its primary endpoint of test specificity comparable to imaging in the study. Sensitivity, however, could not […]

AlzeCure Pharma has completed the clinical phase I study (multiple ascending dose, MAD) with repeated dosing of the drug candidate ACD856, with a focus on Alzheimer’s disease. Data show that ACD856, the primary drug candidate within the company’s NeuroRestore platform, has good tolerability and safety. Furthermore, the results demonstrate that the substance has suitable pharmacokinetic […]

BioInvent International and Transgene have jointly announced positive progress and safety data of the ongoing Phase 1/2a trial evaluating BT-001 in patients with solid tumors, including melanoma. The initial data generated in Phase 1 part A, demonstrated that BT-001 alone is well tolerated, with first signs of anti-tumor activity in a hard-to-treat population and confirmed […]

Two ongoing research studies funded by NordForsk are providing new knowledge about COVID-19 related to pregnancy and mental health. The Nordic countries have similar welfare systems, access to high-quality health data, and publicly funded health services. Together with citizens’ trust in research, this all represents a particular strength in this context, describes NordForsk. Five collaborative […]

For the first time, scientists have succeeded in producing brain scans that detect the presence of alpha-Synuclein. The detection trial was conducted by Dr Oskar Hansson, Professor of Neurology at Lund University and Skåne University Hospital. Hansson and his colleagues used the Swiss company AC Immune’s non-invasive diagnostic imaging agent (PET tracer), ACI-12589, to localize […]